Azlocillin in severe pseudomonas aeruginosa infections

Main Article Content

Hugo Trujillo
Iván Gómez
Gloria Isabel Mejía de R.

Abstract

Fifteen patients with serious infections due to Pseudomonas aeruginosa were treated with azlocill in a new ureidopenicillin. Fourteen out of fifteen bacterial isolates were inhibited (mic) by 32 mcg/ml. or less of the drug. The mean blood concentration of the drug one hour after each i.v. dose was 159.6 mcg/ml. Fourteen (93%) out of the fifteen patients were Clinically and bacteriologically cured. The drug was well tolerated.

Keywords:
Azlocillin, Pseudomonas, Ureidopenicillins

Article Details

Author Biographies

Hugo Trujillo, Pontifical Bolivarian University

Profesor de Pediatría de la Facultad de Medicina de la U.P.B. Investigador CIB.

Iván Gómez, Hospital Pablo Tobon Uribe

Staff Physician at the Pablo Tobón Uribe Hospital. Researcher at the CIB.

Gloria Isabel Mejía de R.

Bacteriologist, Center for Biological Research (CIB).

References

Most read articles by the same author(s)

1 2 > >>